About Beckman Coulter
Beckman Coulter is a Healthcare company based in Brea (United States) founded in 1935 by Arnold O Beckman, and was acquired by Danaher in February 2011. Clinical diagnostic products are manufactured for biomedical testing. It operates on a Direct-to-Consumer (D2C) and Professional Services model. The company has 1,132 employees. Beckman Coulter has completed 8 acquisitions, including Advalytix AG, Cogenics and Cytobank. Its chief executive, as recorded, is J Robert Hurley. Its website beckmancoulter.com draws about 114 thousand monthly visits. Its Indian entity Beckman Coulter India Private Limited reported revenue of βΉ1,465 Cr. Beckman Coulter offers products and services including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation. Its focus areas include Medical Devices and Diagnostic Equipment. Its competitors include Cepheid, Bruker and Blackrock Neurotech; 2 of its 3 listed competitors have raised funding.
Company details
Beckman Coulter is involved in the development and provision of diagnostic solutions for clinical laboratories worldwide. The company focuses on areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking. Innovative products and automation systems are offered to enhance laboratory workflows and improve patient care outcomes. Solutions are provided for critical health issues including antimicrobial resistance, infectious diseases, cardiovascular disease, diabetes, and neurology. Through advanced diagnostics and digital tools, clinical decision-making is supported across various healthcare settings.
- Headquarters Brea, United States
- Employees 1,132
- Founders Arnold O Beckman
- Stage Acquired
- SectorsHealthcare
- Website beckmancoulter.com
- Social LinkedIn X Facebook YouTube
- Acquired by Danaher (Feb 2011)
- Legal Name Beckman Coulter, Inc.
- Date of Incorporation 02 Nov, 2005
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹1,465 Cr
FY 2025 · +11% YoY
- Indian entity net profit₹102 Cr
FY 2025 · 7% margin
- Indian entity EBITDA₹284 Cr
FY 2025 · 20% margin
- InvestorsDanaher
& 3 more
- Employee Count1,132
- Investments & AcquisitionsAdvalytix AG
& 7 more
- Acquired byDanaher
(Feb 2011)
Associated legal entities of Beckman Coulter
Beckman Coulter operates through Beckman Coulter India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Beckman Coulter India Private Limited CIN U33119MH2005PTC157177 | Active | 02 Nov 2005 | Mumbai, Maharashtra | ₹1,465 Cr | 1,132 | 5 | View details |
Products & Services of Beckman Coulter
Beckman Coulter offers a comprehensive portfolio of products and services, including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.
Used for analyzing chemical components in patient samples.
Employed for detecting specific proteins in blood samples.
Designed to automate laboratory workflows for efficiency gains.
Apps and channels of Beckman Coulter
its YouTube channel Beckman Coulter Dx has 704 subscribers and 30 videos.
Videos from Beckman Coulter
The most watched videos on Beckman Coulter's YouTube channel, Beckman Coulter Dx (704 subscribers). Click a video to play it here.
More on Beckman Coulter Dx.
Funding Insights of Beckman Coulter
- Total Rounds 6
- Investors Count 3
All 6 funding rounds of Beckman Coulter with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | Grant | β | β | ||
| Oct 2019 | $1.25M | Grant | β | β | |
| Oct 2016 | $25,666 | Grant | β | β | |
| Jun 2015 | Grant | β | β | ||
| Mar 2015 | $23,971 | Grant | β | β | |
| Jan 2014 | Grant | β | β |
4 investors in total: 4 institutional.
Investors in Beckman Coulter
Beckman Coulter has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Danaher, European Union and Public Health Emergency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| phe.gov | ||||
Innovative health security solutions are funded by BARDA DRIVe. | drive.hhs.gov | |||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Dental equipment and medical instruments are manufactured for therapeutic areas. | 1969 | danaher.com |
Investor details for Beckman Coulter
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Beckman Coulter India Private Limited (Beckman Coulter)
Beckman Coulter India Private Limited is the primary company behind Beckman Coulter. The board of Beckman Coulter India Private Limited currently have 4 directors; the longest-serving is Sameer Ashok Doshi, appointed in 2014. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sameer Ashok Doshi DIN 02701228 | Director | 23 Jun 2014 | 12 yrs 4 mo | Beckman Coulter India Private Limited |
| Venkataraman Ravikumar DIN 08287714 | Director | 09 Nov 2020 | 6 yrs | Beckman Coulter India Private Limited |
| Jamshyd Bomy Patravala DIN 10789724 | Director | 27 Sep 2024 | 2 yrs 1 mo | Beckman Coulter India Private Limited |
| Vinu Varghese DIN 11230656 | Director | 12 Aug 2025 | 1 yr 3 mo | Beckman Coulter India Private Limited |
People of Beckman Coulter
674 people are tracked at Beckman Coulter (132 in leadership, 542 in team); the tracked headcount is 1,132.
| Name | Role | Group |
|---|---|---|
Arnold O Beckman | ex-Founder | Leadership |
J Robert Hurley | CEO & President | Leadership |
Dave Berge | Sr. Director Of Hardware Operations | Leadership |
Yael Sandowski | Director Of Product Development | Leadership |
James Garvin | Director of Open Innovation & Alliance Partnerships (Microbiology) | Leadership |
Robert Ostrom | Finance Director | Leadership |
Sharon Shinn | R&d Director | Leadership |
Michelle MacPherson | Senior Director Of Product Management, Immunoassay | Leadership |
Morten Egeberg | Senior Director, Global Demand Planning | Leadership |
Yip Ban Keat | Senior Director, APAC Supply Chain | Leadership |
Tim Harris | Vice President, Global Logistics And Distribution | Leadership |
Rachel Davison | Senior Director, Program Management | Leadership |
Alexandra Awad | Marketing Director, Eemea | Leadership |
Jeffrey Hill | Sr Director Of Service NACO | Leadership |
Murat M. | Regional Director Of Operations | Leadership |
Zac Jun Zhu | Product Marketing Director | Leadership |
Maria Dimitrova-Martin | Senior Director Supply Chain, Global S&op | Leadership |
Sharon Dowd | Director, Global Product Marketing Chemistry & Immunoassay Solutions | Leadership |
Cartha Donovan | Vice President Global Quality Management Systems | Leadership |
Kathy Xu | Associate Director Of Clinical Affairs | Leadership |
654 more people are available in the full profile.
Complete people profiles for Beckman Coulter
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Beckman Coulter
Figures of Beckman Coulter India Private Limited, the primary company behind Beckman Coulter, for FY 2025. Revenue was ₹1,465 Cr (+11% year on year). Net profit was ₹102 Cr (7% margin). EBITDA was ₹284 Cr (20% margin). Revenue has grown at a compounded annual rate of +11% over three years and +14% over five years.
- ₹1,465 CrRevenue · FY 2025 · +11% YoY
- ₹102 CrNet profit · 7% margin
- ₹284 CrEBITDA · 20% margin
- ₹42.96 CrPaid-up capital
- 1,132Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Beckman Coulter India Private Limited are on its company page.
Detailed financial statements for Beckman Coulter
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beckman Coulter
Beckman Coulter has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Advalytix AG, Cogenics and Cytobank.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Predictive analytics for hospital administration and patient workflows are provided. | stocastic.com | Towson, United States | 2016 | Oct 2022 | β’β’β’β’ | |
Provider of products to measure antibody concentration and host cell stability | valitacell.com | Dublin, Ireland | 2014 | Sep 2022 | β’β’β’β’ | |
Cloud-based platform for single-cell data storage and analysis is provided. | cytobank.org | Santa Clara, United States | 2009 | Jun 2019 | β’β’β’β’ | |
Acoustic liquid handling is developed for life science research. | labcyte.com | Sunnyvale, United States | 2000 | Jan 2019 | β’β’β’β’ | |
Flow cytometer research applications are developed for nanoscale object detection. | xitogen.com | Suzhou, China | 2013 | Apr 2014 | β’β’β’β’ | |
Provides single cell molecular analysis, and the miniaturization of biological tests for R&D | advalytix.com | Munich, Germany | 2000 | Jun 2009 | β’β’β’β’ | |
Gene synthesis, sequencing, and molecular biology services are provided. | cogenics.com | 0 | Apr 2009 | $17M | ||
Chemiluminescent reagents are manufactured for biotechnology applications. | lumigen.com | Southfield, United States | 1987 | Oct 2006 | $185M |
Complete acquisition details for Beckman Coulter
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Beckman Coulter
12 dated milestones of Beckman Coulter across 87 years, from founding to its latest funding, stage changes and deals.
- Founded Beckman Coulter is founded.
- Acquisition Acquires Lumigen.
- Acquisition Acquires Cogenics.
- Acquisition Acquires Advalytix AG.
- Exit Acquired by Danaher.
- Funding First funding round.
- Acquisition Acquires Xitogen Technologies.
- Acquisition Acquires LabCyte.
- Acquisition Acquires Cytobank.
- Funding Latest funding round, Grant,.
- Acquisition Acquires Valitacell.
- Acquisition Acquires StoCastic.
Competitors of Beckman Coulter
Beckman Coulter has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Bruker and Blackrock Neurotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cepheid.com | 1996 | Sunnyvale, United States | $19.1M | 1,299 | Developer of molecular diagnostic testing solutions | |
| bruker.com | 1960 | United States | 9,707 | Diversified research instrument systems are manufactured and supplied. | ||
| blackrockneurotech.com | 2008 | Salt Lake, United States | $22.37M | 127 | Medical devices for neurological therapies are developed. |
Detailed competitors of Beckman Coulter
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Beckman Coulter
The website of Beckman Coulter (beckmancoulter.com) receives about 113.9K visits a month.
- Monthly visits113.9K
▲ 21.3% vs previous month
Websites whose visitors overlap most with Beckman Coulter. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
core-genomics.blogspot.com | core-genomics.blogspot.com | 100% | β | ||
| bio-rad.com | 100% | 665.2K | #79,666 | View details | |
rpicorp.com | rpicorp.com | 96% | #1,292,794 | β | |
| miltenyibiotec.com | 93% | 192.6K | #205,424 | View details | |
| denovosoftware.com | 90% | 28.1K | #1,461,335 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Beckman Coulter
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Beckman Coulter (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beckman Coulter
Complete news archive for Beckman Coulter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beckman Coulter
Beckman Coulter was founded in 1935 and raised its 1st funding round 79 years after it was founded.
Beckman Coulter is headquartered in Brea, United States. It is registered at Brea, California, United States.
J Robert Hurley is the CEO of Beckman Coulter, as recorded in our data.
Beckman Coulter has 1,132 employees.
The primary company behind Beckman Coulter, Beckman Coulter India Private Limited, reported revenue of βΉ1,465 Cr for FY 2025, up 11% year on year.
Beckman Coulter is involved in the development and provision of diagnostic solutions for clinical laboratories worldwide. The company focuses on areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking. Innovative products and automation systems are offered to enhance laboratory workflows and improve patient care outcomes. Solutions are provided for critical health issues including antimicrobial resistance, infectious diseases, cardiovascular disease, diabetes, and neurology. Through advanced diagnostics and digital tools, clinical decision-making is supported across various healthcare settings.
Beckman Coulter's top competitors include Cepheid, Blackrock Neurotech and Bruker.
Beckman Coulter offers DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.
Beckman Coulter has made 8 acquisitions, including Advalytix AG, Cogenics, and Cytobank.
Beckman Coulter has 4 investors. Key investors include Danaher, European Union, Public Health Emergency, and BARDA DRIVe.
Beckman Coulter operates through Beckman Coulter India Private Limited.
Yes. Beckman Coulter was acquired by Danaher in February 2011.

